Number of patients who received the service with the main diagnosis C67 (bladder cancer) or the main diagnosis Z51 and the co-diagnosis C67, and the value of benefits: Difference between revisions
From Beacon
m (Update categories.) |
m (Update categories.) |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 32: | Line 32: | ||
<span style="display:none">dataStart::2013</span> | <span style="display:none">dataStart::2013</span> | ||
<span style="display:none">dataEnd::2020</span> | <span style="display:none">dataEnd::2020</span> | ||
<span style="display:none">dataAvailability::publicly available</span> | <span style="display:none">dataAvailability::publicly available</span> | ||
<span style="display:none">hasDownloadableData::XML</span> | <span style="display:none">hasDownloadableData::XML</span> | ||
<span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span> | |||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | ||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | <span style="display:none">hasCancerType::C00-C97: All cancer types</span> | ||
<span style="display:none">Renal</span> | |||
<span style="display:none">Urothelial</span> | |||
<span style="display:none">Ureteral</span> | |||
<span style="display:none">Urethral</span> | |||
Latest revision as of 12:05, 14 December 2025
Go back to Compilation: NFZ (Poland) page
Type of database: administrative/claims data.
Type of Information: longitudinal. year; sex; age group; Type of benefit; Refund value and number of patients.
Source of Information: Data prepared on the basis of data from the National Health Fund headquarters as of 2021-11-10.
Data level: national level.
Number of Records: unknown.
Date Range: 2013-2020.
Cancer Areas of Interest: C64-C68: Urinary system cancers. Click here to learn more.
Data access: publicly available. Click here to access. Data can be downloaded in the XML format.
Contact information: Click here to access.
